July 24, 2017 7:29 PM ET

Professional Services

Company Overview of BioNJ Inc.

Company Overview

BioNJ Inc. operates a network of members representing research-based life sciences companies and other related contributors. It stimulates and supports the discovery, development, and commercialization of therapies and cures by companies engaged in biopharmaceutical, biomedical, bio-agricultural, and bio-remedial endeavors. The company also provides purchasing consortium programs; and talent services, such as mentor networks, talent acquisitions, training and education, transition programs, HR networking, jobs databases and links, and specialty services for human resources and staffing requirements. In addition, it offers programs on project management, leadership, Six Sigma, root cause anal...

1255 Whitehorse-Mercerville Road

Building B – Suite 514

Trenton, NJ 08691

United States

Founded in 1994

Phone:

609-890-3185

Fax:

609-581-8244

Key Executives for BioNJ Inc.

Chief Executive Officer, President and Trustee
Vice President of Operations
Treasurer and Trustee
Secretary and Trustee
Vice President of Communications and Marketing
Compensation as of Fiscal Year 2017.

BioNJ Inc. Key Developments

BioNJ Inc. Presents at Seventh Annual BioPartnering Conference, May-23-2017 09:00 AM

BioNJ Inc. Presents at Seventh Annual BioPartnering Conference, May-23-2017 09:00 AM. Venue: Busch Campus Center, Rutgers University, 604 Bartholomew Road, Piscataway, NJ 08854, United States. Speakers: Debbie Hart, Chief Executive Officer, President and Trustee.

BioNJ Inc. Presents at BioNJ's 4th Annual CEO Summit, Sep-23-2016 08:15 AM

BioNJ Inc. Presents at BioNJ's 4th Annual CEO Summit, Sep-23-2016 08:15 AM. Venue: Bridgewater Marriott, New Jersey, United States. Speakers: Debbie Hart, Chief Executive Officer, President and Trustee.

BioNJ Approves Appointment of Daniel J. O’Connor to Board of Directors

Advaxis Inc. announced that Daniel J. O’Connor, President and Chief Executive Officer, has been elected to the Board of Trustees of BioNJ. The election took place at the annual meeting of BioNJ. Mr. O’Connor has 20 years of executive, legal and regulatory experience in the biopharmaceutical industry, including senior leadership positions at ImClone Systems and PharmaNet. At ImClone, Mr. O’Connor served as senior vice president, general counsel and secretary, and he supported the clinical development, launch and commercialization of ERBITUX® (cetuximab), and helped resolve corporate issues, including extensive licensing negotiations, in advance of its sale to Eli Lilly in 2008.

Similar Private Companies By Industry

Company Name Region
1-2-3 Payroll & HR Services, Inc. United States
120 Water Audit, LLC United States
123College.com, Inc. United States
13D Research LLC United States
1410 Partners, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioNJ Inc., please visit bionj.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.